If you’ve spent any time in skincare or hair-growth content lately, you’ve probably seen GHK-Cu mentioned as one of the ingredients to know about. It’s turned up in serums, scalp treatments, and “skin longevity” routines, usually promising firmer skin, fewer fine lines, and healthier hair.
But new search data shows the story has moved beyond skincare shelves – and not necessarily in a good way.
What actually is GHK-Cu?
GHK-Cu (also called copper tripeptide-1) is a naturally occurring copper-binding peptide. It’s been used in topical cosmetic products for years, generally positioned around skin firmness, texture, and overall appearance.
As an ingredient in a serum or cream, it’s a pretty unremarkable, well-established part of the peptide skincare world.
So why is everyone suddenly searching for it?
According to search data analysed by Licensed Peptides (via Glimpse), searches for “GHK-Cu” have risen 6,407% over the past year, hitting around 51,000 searches in the most recent month alone.
That’s a huge jump for what used to be a fairly niche ingredient – but it makes sense. GHK-Cu sits right at the crossover of several trends people can’t stop talking about right now: peptides, skin longevity, hair growth, and anti-ageing. It was only a matter of time before it broke into the mainstream.
The concerning part: “GHK-Cu injectable” searches are up nearly 6,000% too
Here’s where it gets more serious. The same data shows searches specifically for “GHK-Cu injectable” have increased 5,985% in a year, reaching roughly 15,000 searches in the last month.
Five-year trend data shows this interest was essentially non-existent until recently, before climbing sharply through 2026.
Dr Samuel Sarmiento, MD, MPH, MBA of Licensed Peptides, put the distinction bluntly: seeing an ingredient listed in a skincare serum is not the same thing as sourcing a vial of it online to inject yourself.
The likely path is one a lot of us will recognise – someone sees GHK-Cu mentioned in a skincare video, searches the ingredient out of curiosity, and ends up served injectable versions marketed as a “stronger” or “faster” alternative. The fact that something is searchable and buyable online doesn’t mean it’s been shown to actually work the way it’s marketed.
Why injectable versions are a different risk category entirely
This is really the crux of it: applying something to your skin and injecting it into your body are not comparable in terms of risk.
Dr Sarmiento flagged a few specific concerns with self-sourced injectable peptides:
- Unregulated sourcing – many of these products are sold via websites with little to no oversight
- “Research use only” labelling – often used as a loophole while the same product is marketed for anti-ageing or hair growth
- Unknown sterility, purity, and concentration – there’s no way to verify what’s actually in the vial
- A polished website or large following isn’t proof of safety – marketing presence has no bearing on what’s inside the product
Worth noting: the FDA has already flagged safety concerns around compounded injectable GHK-Cu, pointing to a possible immunogenicity risk linked to impurities and aggregation, and stating that human safety data remains limited. Injectable and non-injectable versions are being treated as separate regulatory questions altogether.
The takeaway if you’re peptide-curious
None of this means GHK-Cu deserves to be cancelled as a skincare ingredient – it doesn’t. The point Dr Sarmiento was keen to stress is that a legitimate topical ingredient shouldn’t be confused with an unregulated injectable version sold online.
If you like the idea of copper peptides for your own routine, the sensible move is sticking to topical products from an established, reputable skincare brand or retailer, not a vial from a site you found through a targeted ad. “More” isn’t automatically “better,” and an ingredient’s popularity in skincare says nothing about whether an injectable version of it is safe.
Search data and expert commentary via Licensed Peptides, based on analysis of Google search trends using Glimpse.
